John Papastergiou

597 total citations
29 papers, 437 citations indexed

About

John Papastergiou is a scholar working on Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, John Papastergiou has authored 29 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 8 papers in Geriatrics and Gerontology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in John Papastergiou's work include Pharmaceutical Practices and Patient Outcomes (8 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Influenza Virus Research Studies (3 papers). John Papastergiou is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (8 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Influenza Virus Research Studies (3 papers). John Papastergiou collaborates with scholars based in Canada, United Kingdom and Netherlands. John Papastergiou's co-authors include Wilson Li, Bart J. F. van den Bemt, Jane Li, Leslie Young, Lena C. Quilty, Esha Jain, Marco Fonzo, G. Gavazzi, John D. Grabenstein and Giuseppe Del Giudice and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Heart Journal and BMC Public Health.

In The Last Decade

John Papastergiou

28 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Papastergiou Canada 12 131 110 95 62 58 29 437
Lynn Weekes Australia 13 104 0.8× 111 1.0× 125 1.3× 42 0.7× 42 0.7× 34 558
Nico Gabriel United States 9 85 0.6× 63 0.6× 142 1.5× 32 0.5× 60 1.0× 41 526
Tracey Thornley United Kingdom 16 192 1.5× 120 1.1× 229 2.4× 44 0.7× 39 0.7× 41 657
Ahmed Y. Mayet Saudi Arabia 12 59 0.5× 41 0.4× 211 2.2× 61 1.0× 49 0.8× 25 477
Kathryn Slayter Canada 12 284 2.2× 224 2.0× 71 0.7× 34 0.5× 17 0.3× 32 549
Monika Lutters Switzerland 10 169 1.3× 40 0.4× 170 1.8× 15 0.2× 49 0.8× 30 509
Harith Al-Qazaz Iraq 11 146 1.1× 80 0.7× 169 1.8× 10 0.2× 55 0.9× 35 709
Nicole T. Ansani United States 11 115 0.9× 41 0.4× 71 0.7× 14 0.2× 52 0.9× 18 495
Ingebjørg Buajordet Norway 9 221 1.7× 108 1.0× 265 2.8× 42 0.7× 62 1.1× 17 838
M Al-Haddad Saudi Arabia 10 99 0.8× 40 0.4× 127 1.3× 21 0.3× 19 0.3× 22 406

Countries citing papers authored by John Papastergiou

Since Specialization
Citations

This map shows the geographic impact of John Papastergiou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Papastergiou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Papastergiou more than expected).

Fields of papers citing papers by John Papastergiou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Papastergiou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Papastergiou. The network helps show where John Papastergiou may publish in the future.

Co-authorship network of co-authors of John Papastergiou

This figure shows the co-authorship network connecting the top 25 collaborators of John Papastergiou. A scholar is included among the top collaborators of John Papastergiou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Papastergiou. John Papastergiou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Papastergiou, John & Tom Smiley. (2022). Evaluation of Current Hazardous Drug Exposure Control in Community Pharmacy. Journal of Pharmacy Technology. 38(3). 155–158.
2.
Papastergiou, John, et al.. (2021). Pharmacogenomics guided versus standard antidepressant treatment in a community pharmacy setting: A randomized controlled trial. Clinical and Translational Science. 14(4). 1359–1368. 33 indexed citations
3.
Guilcher, Sara J. T., Olavo Fernandes, Gary Wong, et al.. (2020). A developmental evaluation of an intraprofessional Pharmacy Communication Partnership (PROMPT) to improve transitions in care from hospital to community: A mixed-methods study. BMC Health Services Research. 20(1). 99–99. 6 indexed citations
4.
Papastergiou, John, et al.. (2020). Community pharmacy–based H. pylori screening for patients with uninvestigated dyspepsia. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 153(2). 101–107. 5 indexed citations
5.
Donovan, Jacqueline, Yazid N. Al Hamarneh, Beata Bajorek, John Papastergiou, & Ross T. Tsuyuki. (2020). Community pharmacist identification of chronic kidney disease using point-of-care technology: A pilot study. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 153(2). 84–87. 9 indexed citations
6.
Papastergiou, John, et al.. (2020). Pharmacogenetic-guided cannabis usage in the community pharmacy: evaluation of a pilot program. SHILAP Revista de lepidopterología. 2(1). 24–24. 14 indexed citations
7.
Damen, Nikki L., Bart J. F. van den Bemt, Kurt E. Hersberger, et al.. (2019). Creating an Interprofessional guideline to support patients receiving oral anticoagulation therapy: a Delphi exercise. International Journal of Clinical Pharmacy. 41(4). 1012–1020. 6 indexed citations
8.
Costa, Filipa Alves da, Kateřina Malá‐Ládová, Vivian Lee, et al.. (2019). Awareness campaigns of atrial fibrillation as an opportunity for early detection by pharmacists: an international cross-sectional study. Journal of Thrombosis and Thrombolysis. 49(4). 606–617. 10 indexed citations
9.
Ecarnot, Fiona, Gaetano Crepaldi, Philippe Juvin, et al.. (2019). Pharmacy-based interventions to increase vaccine uptake: report of a multidisciplinary stakeholders meeting. BMC Public Health. 19(1). 1698–1698. 51 indexed citations
10.
Papastergiou, John, et al.. (2019). Medication management issues identified during home medication reviews for ambulatory community pharmacy patients. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 152(5). 334–342. 8 indexed citations
11.
Alsabbagh, Mhd Wasem, et al.. (2018). Pharmacy patron perspectives of community pharmacist administered influenza vaccinations. Research in Social and Administrative Pharmacy. 15(2). 202–206. 12 indexed citations
12.
Papastergiou, John, et al.. (2018). Community pharmacist–directed point-of-care group A Streptococcus testing: Evaluation of a Canadian program. Journal of the American Pharmacists Association. 58(4). 450–456. 29 indexed citations
13.
Leblanc, Kori, William Semchuk, John Papastergiou, et al.. (2018). A pharmacist checklist for direct oral anticoagulant management: Raising the bar. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 151(2). 102–106. 7 indexed citations
14.
Papastergiou, John, Nadir Kheir, Sotiris Antoniou, et al.. (2017). Pharmacists’ confidence when providing pharmaceutical care on anticoagulants, a multinational survey. International Journal of Clinical Pharmacy. 39(6). 1282–1290. 17 indexed citations
15.
Papastergiou, John, et al.. (2016). Community pharmacy rapid influenza A and B screening. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 149(2). 83–89. 17 indexed citations
16.
Papastergiou, John, et al.. (2014). Community pharmacist–administered influenza immunization improves patient access to vaccination. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 147(6). 359–365. 96 indexed citations
17.
Papastergiou, John, et al.. (2013). Domperidone withdrawal in a breastfeeding woman. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 146(4). 210–212. 11 indexed citations
18.
Papastergiou, John, et al.. (2013). Home medication reviews by community pharmacists. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 146(3). 139–142. 15 indexed citations
19.
Papastergiou, John, et al.. (2012). HbA1c testing in the community pharmacy: A new strategy to improve care for patients with diabetes. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 145(4). 165–167. 10 indexed citations
20.
Papastergiou, John, et al.. (2002). Audit of IV Pantoprazole: Patterns of Use and Compliance with Guidelines. The Canadian Journal of Hospital Pharmacy. 55(1). 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lynn Weekes Breakdown of academic impact, for papers by Nico Gabriel Breakdown of academic impact, for papers by Tracey Thornley Breakdown of academic impact, for papers by Ahmed Y. Mayet Breakdown of academic impact, for papers by Kathryn Slayter Breakdown of academic impact, for papers by Monika Lutters Breakdown of academic impact, for papers by Harith Al-Qazaz Breakdown of academic impact, for papers by Nicole T. Ansani Breakdown of academic impact, for papers by Ingebjørg Buajordet Breakdown of academic impact, for papers by M Al-Haddad
Rankless by CCL
2026